ArticleCureus2026
Lymphatic Recovery and Clinical Implications in Hand Allotransplantation: Insights From Indocyanine Green Lymphangiography.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Hand vascularized composite allotransplantation (VCA) is currently considered a promising reconstructive approach for selected hand amputees. The major limitation of hand VCA is its risk of rejection, which influences the long-term survival of the allograft. The lymphatic system plays a key role in inflammation, antigen presentation, and immune regulation, yet lymphatic regeneration following upper limb VCA is poorly understood. The correlation between donor-recipient lymphatic reconnection and the allograft recovery and rejection is not well understood. This study was designed to describe lymphatic drainage patterns following upper limb transplantation using indocyanine green lymphangiography (ICG-L) and to explore descriptive associations between these patterns and clinical graft status. Materials and methods This single-center, descriptive case series included seven patients who underwent bilateral upper limb transplantation in the tertiary care facility. ICG-L was performed on one transplanted limb per patient at a single, randomly selected follow-up time point. Indocyanine green dye was injected intradermally at the first webspace, fourth webspace, and the ulnar aspect of the wrist on the flexor surface. The lymphatic flow was visualized using near-infrared fluorescence imaging. Lymphatic drainage patterns were assessed within the allograft, across the donor-recipient interface, and in the recipient limb, and were categorized as linear (normal) or non-linear (abnormal) using Yamamoto's classification. Clinical data, including limb edema and biopsy-proven rejection episodes, were collected. All data were analyzed descriptively; no formal statistical correlation was performed. Results ICG-L was performed with timing varied from three months to four years and two months post-transplant. No adverse reactions to indocyanine green were observed. Six patients had no clinical lymphedema, while one patient demonstrated persistent edema associated with chronic rejection. A total of 21 rejection episodes were documented. Limbs demonstrating linear lymphatic flow at the donor-recipient interface accounted for 12 rejection episodes, while limbs with non-linear flow accounted for nine episodes. Lymphatic continuity into the recipient limb was observed in all but one supracondylar-level transplant. Conclusion Lymphatic regeneration occurs following upper limb VCA despite the absence of surgical lymphatic anastomosis. The observed lymphatic patterns may reflect the complex role of lymphatics in edema resolution and alloimmune responses. The findings in this study are exploratory, and they highlight the need for further research on lymphatic reconnection and its potential for improving allograft function and immunotolerance. Limitations include a small sample size and a lack of serial time-bound measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.